Navigation Links
Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology
Date:7/7/2011

Y was not a prospective study, our findings must be interpreted conservatively," Professor Sangro explained.  "What we can say, based on our evaluation of a broad range of patients with HCC treated in routine clinical practice, is that radioembolization using SIR-Spheres directly targets tumours and spares viable liver tissue, which enables us to reduce the burden of disease and potentially increase both the patient's survival and quality of life.  The greatest survival benefit can be expected in those patients with better performance status, fewer tumour nodules and no occlusion of the portal vein.  

"It is also clear from our analysis," he added, "that radioembolization may be particularly helpful in four specific patient populations.  These include, firstly, patients who might otherwise be considered for TACE but may benefit more from SIR-Spheres; patients who are poor candidates for TACE due to the high number of tumour nodules (>5) or spread to both lobes of the liver; patients who have previously failed TACE; and, finally, patients who are ineligible for TACE because of portal vein occlusion.  These patients have few other treatment options."

Other treatment options that have been demonstrated to extend survival for patients with inoperable HCC include TACE, which requires repeated interventional procedures and hospitalisation due to the resulting post-embolisation syndrome; and sorafenib, an oral medication taken twice daily which can give side effects leading to discontinuation of the drug in more than a third of patients (38%).[3]

The ENRY collaboration found that radioembolization was very well-tolerated by these otherwise ill patients.  More than half (54.5%) experienced fatigue; around one third (32.0%) reported nausea or vomiting; while slightly more than a quarter (27.1%) reported abdominal pain and one in ten reported a mild fever.  These symptoms were transien
'/>"/>

SOURCE ENRY Trialists
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
8. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
9. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
10. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
11. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... de noviembre de 2014  BioClinica®, Inc., un ... y tecnologías eClinical, ha indicado un aumento de ... para el seguimiento basado en el riesgo en ... concepto del seguimiento basado en el riesgo más ... de seguimiento o cambio de los métodos de ...
(Date:11/22/2014)... 21, 2014 Research and Markets  has announced ... Industry Report, 2014-2017" report to their offering. ... Chinese recombinant protein drug market has been expanding rapidly ... and the like. During 2005-2013, sales of recombinant protein ... CAGR of 19.1%, and it is projected that ...
(Date:11/21/2014)... SAN DIEGO , Nov. 21, 2014 /PRNewswire/ ... TNDM ), a medical device company and ... today announced a partnership with Tidepool, a non-profit ... an open source software platform that increases diabetes ... the Tidepool Platform, which is currently under development, ...
Breaking Medicine Technology:El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
... Codexis, Inc. (Nasdaq: CDXS ) today announced the ... to be held in New York, NY on May 18-19, ... will appear on a panel titled "Biofuels" scheduled for May ... not been provided by the conference organizers. Further information will ...
... Pa., May 4, 2011 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Bank of America Merrill Lynch ... the Encore at Wynn Las Vegas.  Mr. Armando Anido, ... an overview of the Company and its product pipeline ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference 2Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference 3
(Date:11/24/2014)... Recently, SweetDressy.com, a well-known dress supplier ... collection of 2014 Evening Dresses. All these fresh items ... company’s marketing manager, the special offer is valid until ... , Sweetdressy.com has been working well in the fashion ... latest designs. Their new dresses may be the best ...
(Date:11/24/2014)... 2014 SafeHandles™ announced that they will ... Ed Begley Jr, airing via Discovery Channel. Dates and ... a passive, non-invasive, replaceable, and affordable germ protective device. ... shrinkable sleeves and adhesives to promote hand hygiene in ... core of SafeHandles is the desire to make a ...
(Date:11/23/2014)... 2014 The clinical trial report, ... data on the Aspergillosis clinical trial scenario. This ... the clinical trials on Aspergillosis. It includes an ... status as per the site of trial conduction ... coverage of disease clinical trials by their phase, ...
(Date:11/23/2014)... BC (PRWEB) November 23, 2014 Pro Ace ... announced that it will now be providing an 8 year ... of hot water tank installations went up due to the ... to assure its customers of the premium service that the ... offering 8 year warranty on John Wood and Bradford hot ...
(Date:11/23/2014)... This evaluation provides a basic conclusion ... and manufacturing technological innovation. Then, the evaluation investigates ... in information. In this part, the evaluation provides ... and 2009-2014 market shares for each company. Through ... and Chinese suppliers finish market of Femoral Occurs ...
Breaking Medicine News(10 mins):Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4
... transplantation of stem cells from a healthy donor (allogeneic) ... aggressive form of chronic lymphocytic leukemia (CLL), irrespective of ... disease. The German CLL Study Group proved this in ... Dr. Peter Dreger, senior consultant and head of the ...
... evaluating the effectiveness of a broad selection of popular ... has found no evidence that any of them facilitate ... presented today (Monday) at the International Congress on Obesity ... effective than the fake supplements they were compared with. ...
... cancer patients who reported poor sleep quality one year after ... dry mouth related to radiation treatments, according to a recent ... Because these side effects can be controlled or modified, the ... cancer patients may be warranted to improve sleep hygiene and ...
... immediate antiretroviral treatment (ART) for infected individuals could have a ... a new study finds that it would not halt the ... a paper that will appear in the August 15 issue ... online, researchers find that the so-called "test-and-treat" strategy could reduce ...
... ... company (Pink Sheets: GDAR), has terminated it,s previously announced strategic alliance with JK Development ... ... Inc., a publicly traded company (Pink Sheets: GDAR), has terminated it,s previously announced strategic ...
... The Kristen Renee ... local campaign set out to fight for the city residents continues to fight for answers ... and BBQ., , ... 9, 2010 -- The Kristen Renee Foundation has launched a campaign to research and investigate ...
Cached Medicine News:Health News:Stem cell transplantation of therapy-resistant chronic leukemia successful 2Health News:New research finds no evidence that popular slimming supplements facilitate weight loss 2Health News:New research finds no evidence that popular slimming supplements facilitate weight loss 3Health News:Pain, dry mouth may play role in sleep quality of head and neck cancer patients 2Health News:Pain, dry mouth may play role in sleep quality of head and neck cancer patients 3Health News:Universal HIV testing and immediate treatment could reduce but not eliminate HIV/AIDS epidemic 2Health News:Golden Age Resources, Inc Terminates Alliance with JK Development of Palm Beach County LLC. 2Health News:The Kristen Renee Foundation Continues to Fight for Frederick, MD for Answers from the EPA and Fort Deterick 2Health News:The Kristen Renee Foundation Continues to Fight for Frederick, MD for Answers from the EPA and Fort Deterick 3Health News:The Kristen Renee Foundation Continues to Fight for Frederick, MD for Answers from the EPA and Fort Deterick 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: